MBCL-29. PHASE I/II STUDY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH STEM CELL SUPPORT IN CHILDREN YOUNGER THAN 5 YEARS OF AGE WITH HIGH-RISK MEDULLOBLASTOMA

PURPOSE: To assess the 3-year EFS rate of children younger than 5 years of age with high-risk medulloblastoma (MB) treated according to the prospective multicenter trial HR MB-5. PATIENTS AND METHODS: After surgery, all children received 2 cycles of Etoposide- Carboplatine. If partial (PR) or comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufour, Christelle, Masliah-Planchon, Julien, Delisle, Marie-Bernadette, Geoffray, Anne, Abbas, Rachid, Bourdeaut, Franck, Bertozzi, Anne-Isabelle, Faure-Conter, Cecile, Chappe, Celine, De Carli, Emilie, Entz-Werle, Natacha, Fouyssac, Fanny, Andre, Nicolas, Soler, Christine, Pluchart, Claire, Palenzuela, Gilles, Leblond, Pierre, Grill, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715253/
http://dx.doi.org/10.1093/neuonc/noaa222.505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715253/
http://dx.doi.org/10.1093/neuonc/noaa222.505

Ejemplares similares